60 Degrees Pharmaceuticals
SXTP
NASDAQ
IPO2023
about SXTP
60 Degrees Pharmaceuticals develops therapeutic agents targeting central nervous system disorders, including epilepsy and schizophrenia, with a focus on improving patient outcomes through innovative treatment solutions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.99 | $8.62 | $5.08 | $2.57M | 168.02M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.66 | n/a | 46.70 | -531.42% | -529.48% | 0% |